CVR 44201666Private limited company (ApS)Engroshandel med læge- og hospitalsartikler (464620)SøborgFounded 17 Jul 2023
Compiled by Dandex from the Central Business Register (CVR, datacvr.virk.dk), Erhvervsstyrelsen, and annual reports filed in XBRL. Values marked Dandex estimate are computed by Dandex from that data, not registered.
Dandex is Danish company data. Connect it once and ask about Vantive ApS, or any Danish company, from your assistant, the API or the command line. Answers come from the current record: owners and the ownership network, financials year by year, and the latest registered changes.
Set Up DandexEmployees
17
CVR registry, Aug 2026
-4 (-19%) over 12 months
Revenue
87.1M
DKK, annual report 2025
+3.2% on 2024
Result
+3.9M
DKK, annual report 2025
Equity
20.6M
DKK, annual report 2025
Vantive Holding B.V.100% of capital and votes, since 3 May 2024
Marianne Schjelderup Brodersensince 18 Dec 2024
100% of capital and votessince 3 May 2024
Holders of 5% or more, from the owner register. CVR records shares in bands, not exact figures.
100% of capital and votes17 Jul 2023 to 3 May 2024
CVR records founders at incorporation. It does not record whether they are alive or still involved.
17 Jul 2023 to 5 Nov 2026.
17 Jul 2023 to 5 Nov 2026.
Aug 2026, monthly: 17 employees, 16 FTE
Arrow keys move through the periods, Home and End go to the first and the latest, Escape returns to the latest.
| Period | Apr 2024 | May 2024 | Jun 2024 | Jul 2024 | Aug 2024 | Sep 2024 | Oct 2024 | Nov 2024 | Dec 2024 | Jan 2025 | Feb 2025 | Mar 2025 | Apr 2025 | May 2025 | Jun 2025 | Jul 2025 | Aug 2025 | Sep 2025 | Oct 2025 | Nov 2025 | Dec 2025 | Jan 2026 | Feb 2026 | Mar 2026 | Apr 2026 | May 2026 | Jun 2026 | Jul 2026 | Aug 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Employees | 20 | 22 | 21 | 21 | 22 | 20 | 20 | 21 | 19 | 19 | 19 | 18 | 19 | 21 | 21 | 20 | 21 | 20 | 20 | 20 | 20 | 20 | 20 | 19 | 19 | 18 | 18 | 17 | 17 |
| FTE | 19 | 21 | 20 | 19 | 21 | 19 | 18 | 19 | 19 | 17 | 18 | 18 | 19 | 20 | 20 | 18 | 19 | 18 | 18 | 19 | 19 | 19 | 19 | 18 | 19 | 18 | 18 | 16 | 16 |
| Series | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly |
The legal entity's own headcount as CVR records it, not the annual report's average, which may cover a group. Monthly Apr 2024 to Aug 2026.
Latest Aug 2026, published 21 Oct 2026. Source: CVR employment series (Årsbeskæftigelse, Kvartalsbeskæftigelse, Månedsbeskæftigelse).
| Metric | 2023 | 2024 | 2025 |
|---|---|---|---|
| Revenue | Not reported | 84,357 | 87,090 |
| Gross profit | -57 | 23,354 | 18,226 |
| Operating profit | -57 | +6,053 | +2,555 |
| Result for the year | -47 | +4,826 | +3,905 |
| Equity | -7 | 16,667 | 20,572 |
| Total assets | 53 | 51,717 | 57,694 |
| Employees (average) | Not reported | 15 | 19 |
| Credit metrics (Dandex calculations) | |||
| Revenue growth (omsætningsvækst) | Not reportednote 1 | Not reportednote 2 | 3.2% |
| EBIT margin (overskudsgrad) | Not reported | 7.2% | 2.9% |
| EBITDA | -57 | 8,265 | 3,715 |
| EBITDA margin | Not reported | 9.8% | 4.3% |
| Employee growth (vækst i antal ansatte) | Not reportednote 3 | Not reportednote 2 | 26.7% |
| Net interest-bearing debt (NIBD, nettorentebærende gæld) | 3 | Not reportednote 4 | 7 |
| Gearing, NIBD / EBITDA | Not reportednote 2 | Not reportednote 4 | 0x |
| NIBD incl. group and owner balances (NIBD inkl. koncern- og ejermellemværender) | 3 | Not reportednote 4 | -9,408 |
DKK thousands. Annual reports via XBRL. Employees are the annual report's average and may cover a group. Not every period is a full year: 2023 covers 6 months (17 Jul to 31 Dec 2023). Changes against it compare periods of different length.
Credit metrics are Dandex calculations from the filed figures, not filed values; estimates are in grey with a note. Ratios are percentages and gearing a multiple. Definitions. No cash flow statement filed (class A and B are exempt).
ERL ApS registered as new owner of Vantive ApS — indicates new investment.
Signal, a Dandex estimate. Lapses 20 Dec 2026.
Each registered value from the day it took effect, newest first.
Demerger (Spaltning), as the receiving company (Modtagende selskab)
From CVR, read 5 Nov 2026. Text such as the signing rule and purpose is shown as registered.
8 registrations, newest first. As published by Erhvervsstyrelsen, in Danish, with people's street addresses cut to postcode and city.
Revision:
Fratrådte:
PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB, den 23.06.2026.
Tiltrådte:
CVR-NR. 30700228 EY Godkendt Revisionspartnerselskab, Dirch Passers Allé 36, 2000 Frederiksberg, den 23.06.2026.
Direktion:
Fratrådte:
Michal Maciej Smialek, den 18.12.2024.
Tiltrådte:
Marianne Schjelderup Brodersen, den 18.12.2024.
Bestyrelse:
Fratrådte:
Michal Maciej Smialek, (formand), den 28.08.2024.
Tiltrådte:
Ewa Marianna Gorna-Babiker, (formand), den 28.08.2024.
Erhvervsstyrelsen har modtaget oplysning om, at der er truffet beslutning om nedenstående spaltning.
Aktiver og gæld er overdraget fra CVR-nummer: 72246012 BAXTER A/S.
Vedtægter ændret: 01.04.2024
Kapitalforhøjelsen er besluttet den 01.04.2024.
kr. 1,00, indbetalt ved spaltning, kurs 938.641.400,00.
Kapitalen udgør herefter kr. 40.001,00.
Erhvervsstyrelsen har modtaget spaltningsplan for den påtænkte spaltning af CVR-nummer: 72246012 BAXTER A/S (indskydende fortsættende) og CVR-nummer: 44201666 Vantive ApS (modtagende).
Erhvervsstyrelsen har modtaget erklæring fra vurderingsmændene om, at kreditorerne i CVR-nummer: 72246012 BAXTER A/S og CVR-nummer: 44201666 Vantive ApS må antages at være tilstrækkeligt sikrede efter spaltningen.
Vedtægter ændret: 08.09.2023
Første regnskabsår: 17.07.2023 - 31.12.2023
Vedtægter ændret: 16.08.2023
Nyt navn: Vantive ApS
Selskabet tegnes af et medlem af bestyrelsen eller af en direktør alene
Formål ændret: Selskabets formål er handel med og produktion af medicin og farmaceutiske behandlingsmidler og produkter til brug inden for medicinalindustrien samt anden dermed i forbindelse stående virksomhed.
Stiftelsesdato: 17.07.2023.
Virkningsdato: 17.07.2023.
Seneste vedtægtsdato: 17.07.2023.
Kapital:
kr. 40.000,00.
Kapitalklasser: Nej
Indbetalingsmåde: Indbetalt kontant kr. 40.000,00 til kurs 100,00, fuldt indbetalt.
Stifter:
Baxter Netherlands Holding B.V., Kobaltweg 49, 3542 CE Utrecht, Holland, den 17.07.2023.
Bestyrelse:
Michal Maciej Smialek, (formand), den 17.07.2023, Marianne Schjelderup Brodersen, den 17.07.2023.
Direktion:
Michal Maciej Smialek, den 17.07.2023.
Selskabet tegnes af to medlemmer af bestyrelsen i forening eller af en direktør alene
Revision:
CVR-NR. 33771231 PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB, Strandvejen 44, 2900 Hellerup, den 17.07.2023.
Første regnskabsår:
17.07.2023 - 31.12.2024.
Regnskabsår:
01.01 - 31.12.
Formål:
Selskabets formål er handel med og produktion af medicin og farmaceutiske behandlingsmidler og produkter til brug inden for medicinalindustrien samt anden dermed i forbindelse stående virksomhed. Handel med medicinske og farmaceutiske plejeprodukter og produkter til medicinalindustrien og anden virksomhed i forbindelse dermed.
1 registered in CVR.
P-number 1029504284Tobaksvejen 23, 2860 Søborg
No other current company drawn.
No other current company drawn.
